ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Nakada K, Kohakura M, Komoda H, Hinuma K, 1984. High incidence of HTLV antibody in carriers of Strongyloides stercoralis. Lancet 1 :633.
-
2
Robinson RD, Lindo JF, Neva FA, Gam AA, Vogel P, Terry SI, Cooper ES, 1994. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica. J Infect Dis 169 :692–696.
-
3
Carvalho EM, Porto A, 2004. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol 26 :487–497.
-
4
Terashima A, Alvarez H, Tello R, Infante R, Freedman DO, Gotuzzo E, 2002. Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection. Int J Infect Dis 6 :28–30.
-
5
Sato Y, Shiroma Y, Kiyuna S, Toma H, Kobayashi J, 1993. Reduced effect of chemotherapy of strongyloidiasis in patients with concurrent HTLV-1 infection in Okinawa, Japan. Jpn J Trop Med Hyg 20 :183–192.
-
6
Satoh M, Toma H, Sato Y, Takara M, Shiroma Y, Kiyuna S, Hirayama K, 2002. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1. Clin Exp Immunol 127 :354–359.
-
7
Gotuzzo E, Terashima A, Alvarez H, Tello R, Infante R, Watts DM, Freedman DO, 1999. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg 60 :146–149.
-
8
Newton RC, Limpuangthip P, Greenberg S, Gam A, Neva FA, 1992. Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression. Am J Med 92 :202–208.
-
9
Porto AF, Neva FA, Bittencourt H, Lisboa W, Thompson R, Alcantara L, Carvalho EM, 2001. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol 23 :503–507.
-
10
Neva FA, Filho JO, Gam AA, Thompson R, Freitas V, Melo A, Carvalho EM, 1998. Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis. J Infect Dis 178 :1856–1859.
-
11
Fujino R, Kawato K, Ikeda M, Miyakoshi H, Mizukoshi M, Imai J, 1991. Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody. Jpn J Cancer Res 82 :367–370.
-
12
Arakaki T, Iwanaga M, Kinjo F, Saito A, Asato R, Ikeshiro T, 1990. Efficacy of agar-plate culture in detection of Strongyloides stercoralis infection. J Parasitol 76 :425–428.
-
13
Hayashi J, Kishihara Y, Yoshimura E, Furusyo N, Yamaji K, Kawakami Y, Murakami H, Kashiwagi S, 1997. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan. Am J Trop Med Hyg 56 :71–75.
-
14
Walzer PD, Milder JE, Banwell JG, Kilgore G, Klein M, Parker R, 1982. Epidemiologic features of Strongyloides stercoralis infection in an endemic area of the United States. Am J Trop Med Hyg 31 :313–319.
-
15
Matsuoka M, 2003. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 22 :5131–5140.
-
16
Zaha O, Hirata T, Uchima N, Kinjo F, Saito A, 2004. Comparison of anthelmintic effects of two doses of ivermectin on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody. J Infect Chemother 10 :348–351.
-
17
Santos SB, Porto AF, Muniz AL, Jesus AR, Carvalho EM, 2004. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis 4 :7.
-
18
Medhat A, Shehata M, Bucci K, Mohamed S, Dief AD, Badary S, Galal H, Nafeh M, King CL, 1988. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Infect Dis 178 :512–519.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 396 | 363 | 141 |
| Full Text Views | 318 | 4 | 2 |
| PDF Downloads | 112 | 6 | 4 |
IMPAIRMENT OF HOST IMMUNE RESPONSE AGAINST STRONGYLOIDES STERCORALIS BY HUMAN T CELL LYMPHOTROPIC VIRUS TYPE 1 INFECTION
TETSUO HIRATA
TETSUO HIRATA
Control and Prevention of Infectious Diseases, Department of Medicine and Therapeutics, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Endoscopy and Department of Blood Transfusion Medicine, Ryukyu University Hospital, Okinawa, Japan; Department of Internal Medicine, Nakagami Hospital, Okinawa, Japan
Search for other papers by TETSUO HIRATA in
Current site
Google Scholar
PubMed
Search for other papers by TETSUO HIRATA in
Current site
Google Scholar
PubMed
NOBUFUMI UCHIMA
NOBUFUMI UCHIMA
Control and Prevention of Infectious Diseases, Department of Medicine and Therapeutics, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Endoscopy and Department of Blood Transfusion Medicine, Ryukyu University Hospital, Okinawa, Japan; Department of Internal Medicine, Nakagami Hospital, Okinawa, Japan
Search for other papers by NOBUFUMI UCHIMA in
Current site
Google Scholar
PubMed
Search for other papers by NOBUFUMI UCHIMA in
Current site
Google Scholar
PubMed
KAZUTO KISHIMOTO
KAZUTO KISHIMOTO
Control and Prevention of Infectious Diseases, Department of Medicine and Therapeutics, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Endoscopy and Department of Blood Transfusion Medicine, Ryukyu University Hospital, Okinawa, Japan; Department of Internal Medicine, Nakagami Hospital, Okinawa, Japan
Search for other papers by KAZUTO KISHIMOTO in
Current site
Google Scholar
PubMed
Search for other papers by KAZUTO KISHIMOTO in
Current site
Google Scholar
PubMed
OSAMU ZAHA
OSAMU ZAHA
Control and Prevention of Infectious Diseases, Department of Medicine and Therapeutics, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Endoscopy and Department of Blood Transfusion Medicine, Ryukyu University Hospital, Okinawa, Japan; Department of Internal Medicine, Nakagami Hospital, Okinawa, Japan
Search for other papers by OSAMU ZAHA in
Current site
Google Scholar
PubMed
Search for other papers by OSAMU ZAHA in
Current site
Google Scholar
PubMed
NAGISA KINJO
NAGISA KINJO
Control and Prevention of Infectious Diseases, Department of Medicine and Therapeutics, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Endoscopy and Department of Blood Transfusion Medicine, Ryukyu University Hospital, Okinawa, Japan; Department of Internal Medicine, Nakagami Hospital, Okinawa, Japan
Search for other papers by NAGISA KINJO in
Current site
Google Scholar
PubMed
Search for other papers by NAGISA KINJO in
Current site
Google Scholar
PubMed
AKIRA HOKAMA
AKIRA HOKAMA
Control and Prevention of Infectious Diseases, Department of Medicine and Therapeutics, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Endoscopy and Department of Blood Transfusion Medicine, Ryukyu University Hospital, Okinawa, Japan; Department of Internal Medicine, Nakagami Hospital, Okinawa, Japan
Search for other papers by AKIRA HOKAMA in
Current site
Google Scholar
PubMed
Search for other papers by AKIRA HOKAMA in
Current site
Google Scholar
PubMed
HIROSHI SAKUGAWA
HIROSHI SAKUGAWA
Control and Prevention of Infectious Diseases, Department of Medicine and Therapeutics, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Endoscopy and Department of Blood Transfusion Medicine, Ryukyu University Hospital, Okinawa, Japan; Department of Internal Medicine, Nakagami Hospital, Okinawa, Japan
Search for other papers by HIROSHI SAKUGAWA in
Current site
Google Scholar
PubMed
Search for other papers by HIROSHI SAKUGAWA in
Current site
Google Scholar
PubMed
FUKUNORI KINJO
FUKUNORI KINJO
Control and Prevention of Infectious Diseases, Department of Medicine and Therapeutics, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Endoscopy and Department of Blood Transfusion Medicine, Ryukyu University Hospital, Okinawa, Japan; Department of Internal Medicine, Nakagami Hospital, Okinawa, Japan
Search for other papers by FUKUNORI KINJO in
Current site
Google Scholar
PubMed
Search for other papers by FUKUNORI KINJO in
Current site
Google Scholar
PubMed
JIRO FUJITA
JIRO FUJITA
Control and Prevention of Infectious Diseases, Department of Medicine and Therapeutics, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Endoscopy and Department of Blood Transfusion Medicine, Ryukyu University Hospital, Okinawa, Japan; Department of Internal Medicine, Nakagami Hospital, Okinawa, Japan
Search for other papers by JIRO FUJITA in
Current site
Google Scholar
PubMed
Search for other papers by JIRO FUJITA in
Current site
Google Scholar
PubMed
A large-scale study was undertaken to clarify the prevalence rate of strongyloidiasis in Okinawa, Japan and to evaluate the relationship between strongyloidiasis and infection with human T cell lymphotropic virus type 1 (HTLV-1). The prevalence rate of Strongyloides stercoralis and HTLV-1 infection were 6.3% and 14.0%, respectively. Among 2,185 patients more than 50 years of age, the rate of S. stercoralis infection was significantly higher in patients with HTLV-1 infection compared with patients without HTLV-1 infection. In 252 patients treated with ivermectin, serum IgE levels and peripheral eosinophil counts were significantly lower in HTLV-1 co-infected patients compared with patients without HTLV-1 infection. In addition, the anthelmintic effect was significantly lower in patients with HTLV-1 infection compared with patients without HTLV-1 infection. Our prospective study demonstrated a prevalence rate for strongyloidiasis and HTLV-1 infections, and clearly demonstrated that co-infection with HTLV-1 impaired the immune response against S. stercoralis.
Author Notes
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Nakada K, Kohakura M, Komoda H, Hinuma K, 1984. High incidence of HTLV antibody in carriers of Strongyloides stercoralis. Lancet 1 :633.
-
2
Robinson RD, Lindo JF, Neva FA, Gam AA, Vogel P, Terry SI, Cooper ES, 1994. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica. J Infect Dis 169 :692–696.
-
3
Carvalho EM, Porto A, 2004. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol 26 :487–497.
-
4
Terashima A, Alvarez H, Tello R, Infante R, Freedman DO, Gotuzzo E, 2002. Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection. Int J Infect Dis 6 :28–30.
-
5
Sato Y, Shiroma Y, Kiyuna S, Toma H, Kobayashi J, 1993. Reduced effect of chemotherapy of strongyloidiasis in patients with concurrent HTLV-1 infection in Okinawa, Japan. Jpn J Trop Med Hyg 20 :183–192.
-
6
Satoh M, Toma H, Sato Y, Takara M, Shiroma Y, Kiyuna S, Hirayama K, 2002. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1. Clin Exp Immunol 127 :354–359.
-
7
Gotuzzo E, Terashima A, Alvarez H, Tello R, Infante R, Watts DM, Freedman DO, 1999. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg 60 :146–149.
-
8
Newton RC, Limpuangthip P, Greenberg S, Gam A, Neva FA, 1992. Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression. Am J Med 92 :202–208.
-
9
Porto AF, Neva FA, Bittencourt H, Lisboa W, Thompson R, Alcantara L, Carvalho EM, 2001. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol 23 :503–507.
-
10
Neva FA, Filho JO, Gam AA, Thompson R, Freitas V, Melo A, Carvalho EM, 1998. Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis. J Infect Dis 178 :1856–1859.
-
11
Fujino R, Kawato K, Ikeda M, Miyakoshi H, Mizukoshi M, Imai J, 1991. Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody. Jpn J Cancer Res 82 :367–370.
-
12
Arakaki T, Iwanaga M, Kinjo F, Saito A, Asato R, Ikeshiro T, 1990. Efficacy of agar-plate culture in detection of Strongyloides stercoralis infection. J Parasitol 76 :425–428.
-
13
Hayashi J, Kishihara Y, Yoshimura E, Furusyo N, Yamaji K, Kawakami Y, Murakami H, Kashiwagi S, 1997. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan. Am J Trop Med Hyg 56 :71–75.
-
14
Walzer PD, Milder JE, Banwell JG, Kilgore G, Klein M, Parker R, 1982. Epidemiologic features of Strongyloides stercoralis infection in an endemic area of the United States. Am J Trop Med Hyg 31 :313–319.
-
15
Matsuoka M, 2003. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 22 :5131–5140.
-
16
Zaha O, Hirata T, Uchima N, Kinjo F, Saito A, 2004. Comparison of anthelmintic effects of two doses of ivermectin on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody. J Infect Chemother 10 :348–351.
-
17
Santos SB, Porto AF, Muniz AL, Jesus AR, Carvalho EM, 2004. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis 4 :7.
-
18
Medhat A, Shehata M, Bucci K, Mohamed S, Dief AD, Badary S, Galal H, Nafeh M, King CL, 1988. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Infect Dis 178 :512–519.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 396 | 363 | 141 |
| Full Text Views | 318 | 4 | 2 |
| PDF Downloads | 112 | 6 | 4 |